Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

NASEM Report on Compounded Topical Pain Creams

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2020 - Volume 24, Number 6
View All Articles in Issue

Page(s):  446-448

NASEM Report on Compounded Topical Pain Creams Page 1
NASEM Report on Compounded Topical Pain Creams Page 2
NASEM Report on Compounded Topical Pain Creams Page 3

Download in electronic PDF format for $75

Abstract:  

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, National Academies of Science, Engineering and Medicine, NASEM, U.S. Food and Drug Administration, FDA, compounded topical pain creams, pain relief, analgesic, analgesia, topical preparations, transdermal administration, drug safety, drug efficacy, dermal penetration, skin absorption, clinical rationale, compounding standards, active pharmaceutical ingredients, drug combinations, pharmacy education

Related Categories: LEGAL, PAIN MANAGEMENT, PHARMACY EDUCATION, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Nov/Dec 2020
Pg. 446-448

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Sep/Oct 2020
Pg. 356

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
Nov/Dec 2020
Pg. 444

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
May/Jun 2021
Pg. 206-209

Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M
, Reed Thomas C
Nov/Dec 2007
Pg. 514-519

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116

A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith
, Tuder Dmitry
May/Jun 2014
Pg. 182-188

PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
Jan/Feb 2021
Pg. 4

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Return to Top